{"name":"Fundación EPIC","slug":"fundaci-n-epic","ticker":"","exchange":"","domain":"","description":"Fundación EPIC is a non-profit organization focused on developing innovative healthcare solutions, particularly in the area of combination therapies for chronic diseases. The foundation has successfully brought several polypills to market, aiming to improve patient adherence and outcomes.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Essential pro","genericName":"Essential pro","slug":"essential-pro","indication":"Hypertension","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Previous treatment","genericName":"Previous treatment","slug":"previous-treatment","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Essential pro","genericName":"Essential pro","slug":"essential-pro","phase":"marketed","mechanism":"Essential pro works by inhibiting the reabsorption of sodium and water in the kidneys.","indications":["Hypertension","Edema"],"catalyst":""},{"name":"Previous treatment","genericName":"Previous treatment","slug":"previous-treatment","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}